Best DTx - Sleep Products

We help leading organizations provide effective non-drug options for mental health

NightWare develops an application on an Apple Watch that aims to help people suffering from nightmares. The company offers wearable technology that learns sleep patterns and customizes a treatment for each individual. NightWare was founded in 2015 and is based in Hopkins, Minnesota.

SleepRate helps people all over the world sleep better for a healthier, happier and more productive life. SleepRate offers a clinically validated sleep improvement solution to help millions of people who have trouble sleeping. The solution is available through an intuitive mobile app which can be used alone, or together with a wearable tracking device. SleepRate accurately assesses sleep issues and offers a personalized sleep improvement plan to drastically improve sleep quality. SleepRate’s solution is based on a patented and validated sleep analysis algorithm combined with sleep treatment protocols that were developed based on research at the Sleep Clinic of the Stanford University’s School of Medicine, Psychiatry and Behavioral Sciences department.

SleepUp® App is a SaMD (Software as Medical Device) solution that offers clinically validated digital therapy for insomnia and apnea. Integrated and personalized care includes continuous sleep monitoring from wearables and evidence-based intervention based on psychology, medicine, and mindfulness.

Somryst is a digital therapeutic software company that specializes in prescription digital therapeutics for cognitive behavioral therapy. It optimizes and analyzes insomnia symptoms, therapeutic analysis tools, and treatment planning features to treat individuals with insomnia. It was founded in 2020 and is based in Boston, Massachusetts.

Somryst® is the first and only prescription digital therapeutic indicated to treat chronic insomnia. Somryst is intended to improve insomnia symptoms by providing neurobehavioral intervention (cognitive behavioral therapy for insomnia – CBT-I) to adults 22 years of age and older with chronic insomnia.